Tibulizumab Uses, Dosage, Side Effects and more
Tibulizumab is under investigation in clinical trial NCT03736772 (A Study of LY3090106 in Japanese and Caucasian Healthy Participants).
| Attribute | Details |
|---|---|
| Trade Name | Tibulizumab |
| Generic | Tibulizumab |
| Tibulizumab Other Names | Tibulizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
